Bank of Nova Scotia’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-74,000
Closed -$2.06M 943
2019
Q4
$2.06M Buy
+74,000
New +$1.86M 0.01% 677
2019
Q3
Sell
-203,863
Closed -$5.14M 930
2019
Q2
$5.14M Buy
203,863
+14,563
+8% +$391K 0.02% 414
2019
Q1
$5.14M Buy
+189,300
New +$6.35M 0.02% 429
2018
Q4
Sell
-358,594
Closed -$16.7M 892
2018
Q3
$16.7M Buy
358,594
+149,894
+72% +$6.88M 0.07% 227
2018
Q2
$9.03M Sell
208,700
-375,000
-64% -$18M 0.05% 264
2018
Q1
$32.5M Sell
583,700
-79,650
-12% -$4.37M 0.17% 123
2017
Q4
$35.4M Buy
663,350
+163,350
+33% +$7.71M 0.16% 138
2017
Q3
$21.6M Buy
+500,000
New +$23.8M 0.13% 158
2017
Q2
Sell
-9,350
Closed -$649K 969
2017
Q1
$649K Hold
9,350
﹤0.01% 796
2016
Q4
$623K Hold
9,350
﹤0.01% 563
2016
Q3
$619K Hold
9,350
﹤0.01% 481
2016
Q2
$677K Hold
9,350
﹤0.01% 445
2016
Q1
$604K Hold
9,350
﹤0.01% 448
2015
Q4
$670K Hold
9,350
﹤0.01% 458
2015
Q3
$718K Buy
9,350
+3,650
+64% +$295K ﹤0.01% 357
2015
Q2
$422K Hold
5,700
﹤0.01% 395
2015
Q1
$413K Buy
5,700
+2,500
+78% +$174K ﹤0.01% 400
2014
Q4
$211K Buy
+3,200
New +$195K ﹤0.01% 534
2014
Q1
Sell
-70,000
Closed -$3.74M 608
2013
Q4
$3.74M Buy
+70,000
New +$3.76M 0.02% 243

Other funds holding MD

Bank of Nova Scotia's MD Position: Q1 2020 in Review

Bank of Nova Scotia sold out of Pediatrix Medical (MD) in Q1 2020, closing a stake of 74,000 shares — an estimated $2.06M sold.

Bank of Nova Scotia first reported a position in MD in Q4 2013 and held it in 19 quarters. The position peaked at $35.4M in Q4 2017. 221 funds tracked by Wall St. Rank hold MD as of Q1 2020.

  • Bank of Nova Scotia reported no remaining Pediatrix Medical position as of Q1 2020 after selling out during the quarter.
  • Bank of Nova Scotia sold 74,000 Pediatrix Medical shares in Q1 2020, an estimated $2.06M.
  • Bank of Nova Scotia first reported a position in Pediatrix Medical in Q4 2013 and held it in 19 quarters.
  • Bank of Nova Scotia's Pediatrix Medical position peaked at $35.4M in Q4 2017.
  • 221 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2020.

Based on Bank of Nova Scotia's 13F filing for Q1 2020, filed 15 May 2020.